NCT07423481Not yet recruiting
Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity
SEMAFOLLOW - Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity: Observational, National Cohort, Real-world Study in France
Source: ClinicalTrials.gov · Last updated 18 Sept 2026
Brief summary (registry, in English)
SEMAFOLLOW is a real-world follow-up study examining the outcomes of individuals treated with WEGOVY® (semaglutide 2.4 mg) under the temporary authorisation for use (ATU) and early access programme in France. This study evaluates weight change, treatment strategies and well-being, drawing on the expertise of teams from various specialist obesity centres in France.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 13 Feb 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 1 Jul 2027
- Lead sponsor
- Nantes University Hospital
- Diseases
- Obesity
- NCT number
- NCT07423481
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 1 Oct 2026 to the primary completion date, 1 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Protected patients: minors, adults under guardianship, conservatorship, and/or legal protection
Who the study is looking for
- Patients included in the ATU/early access program for WEGOVY with at least two dispenses of WEGOVY
- No objection to the use of their data
- Patients able to complete an online questionnaire (via the internet)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nantes University Hospital Coordinator of this site? Confirm its status | Nantes | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.